相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men
J. -M. Kaufman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density
Eric Orwoll et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
Steven Boonen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication
Jose A. Riancho et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Calcium Supplementation and the Risks of Atherosclerotic Vascular Disease in Older Women: Results of a 5-Year RCT and a 4.5-Year Follow-up
Joshua R. Lewis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Male Osteoporosis: Epidemiology and the Pathogenesis of Aging Bones
Jessica K. Lambert et al.
Current Osteoporosis Reports (2011)
Cost-Effectiveness of Fracture Prevention in Men Who Receive Androgen Deprivation Therapy for Localized Prostate Cancer
Kouta Ito et al.
ANNALS OF INTERNAL MEDICINE (2010)
Efficacy and safety of monthly ibandronate in men with low bone density
Eric S. Orwoll et al.
BONE (2010)
Approach to the patient with secondary osteoporosis
Lorenz C. Hofbauer et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Genetics of osteoporosis: accelerating pace in gene identification and validation
Wen-Feng Li et al.
HUMAN GENETICS (2010)
Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis
Kathryn M. Ryder et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2010)
The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study
T. W. O'Neill et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Incidence of clinically diagnosed vertebral fractures: A population-based study in rochester, minnesota, 1985-1989
Cyrus Cooper et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Efficacy and Safety of a Once-Yearly i.v. Infusion of Zoledronic Acid 5 mg Versus a Once-Weekly 70-mg Oral Alendronate in the Treatment of Male Osteoporosis: A Randomized, Multicenter, Double-Blind, Active-Controlled Study
Eric S. Orwoll et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Adverse Events Associated with Testosterone Administration
Shehzad Basaria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prognosis of fracture: evaluation of predictive accuracy of the FRAX™ algorithm and Garvan nomogram
S. K. Sandhu et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Effects of beer, wine, and liquor intakes on bone mineral density in older men and women
Katherine L. Tucker et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Single Infusion of Zoledronic Acid to Prevent Androgen Deprivation Therapy-induced Bone Loss in Men With Hormone-naive Prostate Carcinoma
Takefumi Satoh et al.
CANCER (2009)
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture
Erik Fink Eriksen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
Steven Boonen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
S. Aubrey Stoch et al.
JOURNAL OF RHEUMATOLOGY (2009)
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Risk factors for low BMD in healthy men age 50 years or older: a systematic review
A. Papaioannou et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Functions of RANKL/RANK/OPG in bone modeling and remodeling
Brendan F. Boyce et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate
Paul D. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Osteoporosis in men
Peter R. Ebeling
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A population-based assessment of rates of bone loss at multiple skeletal sites: Evidence for substantial trabecular bone loss in young adult women and men
B. Lawrence Riggs et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Zoledronic acid and clinical fractures and mortality after hip fracture
Kenneth W. Lyles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Identification of vertebral fracture and non-osteoporotic short vertebral height in men: The MrOS study
Lynne Ferrar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid
Christopher W. Ryan et al.
BJU INTERNATIONAL (2007)
Leisure physical activity and the risk of fracture in men
Karl Michaelsson et al.
PLOS MEDICINE (2007)
The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor κB legend with bone mineral density in older adults:: the Rancho Bernardo Study
Anna Stern et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Early and rapid bone mineral density loss of the proximal femur in men
Peter Nordstrom et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer - A randomized trial
Susan L. Greenspan et al.
ANNALS OF INTERNAL MEDICINE (2007)
The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy
Ron S. Israeli et al.
CLINICAL GENITOURINARY CANCER (2007)
Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men
Howard A. Fink et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
JD Ringe et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Effects of sex and age on bone microstructure at the ultradistal radius: A population-based noninvasive in vivo assessment
S Khosla et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Effect of testosterone replacement on trabecular architecture in hypogonadal men
M Benito et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Free testosterone is a positive, whereas free estradiol is a negative, predictor of cortical bone size in young Swedish men:: The GOOD study
M Lorentzon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Does Alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women
AM Sawka et al.
BMC MUSCULOSKELETAL DISORDERS (2005)
Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men
A Aminorroaya et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy
JM Kaufman et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study
C Meier et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Risk of fracture after androgen deprivation for prostate cancer
VB Shahinian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study
BA Mohr et al.
CLINICAL ENDOCRINOLOGY (2005)
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites
SL Ferrari et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo osteoporosis epidemiology study
KP Chang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone
JK Amory et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The importance of bisphosphonate therapy mass in men after therapy with teriparatide [human parathyroid hormone(1-34)]
ES Kurland et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Prevalence and incidence of androgen deficiency in middle-aged and older men: Estimates from the Massachusetts Male Aging Study
AB Araujo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden
F Borgström et al.
BONE (2004)
The effects of parathyroid hormone, alendronate, or both in men with osteoporosis
JS Finkelstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF UROLOGY (2003)
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
E Orwoll et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteoporosis in men treated with androgen deprivation therapy for prostate cancer
RW Ross et al.
JOURNAL OF UROLOGY (2002)
Biochemical markers of bone turnover in men
P Szulc et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
MR Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: A two-year randomized, double blind, double placebo study
PR Ebeling et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men
C Wang et al.
CLINICAL ENDOCRINOLOGY (2001)
Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists
SA Stoch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Bone turnover markers and sex hormones in men with idiopathic osteoporosis
P Pietschmann et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Clinical review 123:: Hot topic -: Anabolic therapy for osteoporosis
CJ Rosen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Alendronate for the treatment of osteoporosis in men
E Orwoll et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
